go-v.orgdoi

Pharmaceutical Toxicology

William J. Brock, Lorrene A. Buckley · CRC Press eBooks · 2014

  • DOI 10.1201/b16632-21
  • Publisher CRC Press
  • Type book-chapter
  • Issued 2014

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

CRC Press eBooks · CRC Press · book-chapter · 2014

Abstract

This chapter on genetic toxicology is designed to serve as a reference guide to toxicologists and regulatory specialists developing genotoxicity data for product evaluation and regulatory submission. Human exposure to genotoxic chemicals is of regulatory concern due to the association of DNA damage in somatic cells with cancer and other diseases, and DNA damage to germ cells leading to heritable mutations in future generations. Assays for measuring genotoxicity have been in use for over 40 years. There are hundreds of genotoxicity assays and they are generally grouped by the end point that is measured, such as assays for mutations, chromosome alterations, primary DNA damage, and DNA repair.

These end points can be measured in bacteria, yeast, fungi, plants, invertebrates, mammalian cells in culture, animals, and humans. DNA damage potential can be assessed at all stages of drug or chemical development including the use of computer modeling, simple screening assays for lead optimization, standard GLP testing for regulatory submission, and more complex GLP studies to investigate speci˜c issues to help assess human risk. Out of hundreds of assays, a standard battery of tests used within industry and regulatory agencies has been de˜ned with some variations depending on whether the testing is for drugs, cosmetic ingredients, chemicals, etc.

Brie©y, the standard battery consists of both in vitro and in vivo genotoxicity assays. In vitro assays are used for an initial assessment since they have the advantage of being relatively inexpensive and quick. In vivo assays provide a more biologically relevant assessment of genotoxicity since they re©ect normal distribution and metabolism, but require the use of animals and are more timeconsuming and costly than in vitro assays.

Open the resolved locator · 10.1201/b16632-21

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 00:09 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://doi.org/10.1201/b16632-21
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.